This study explains the mechanism by which severe anemia occurs in SF3B1 mutant MDS patients and identifies a direct role for MAP3K7 in the proper regulation of erythroid differentiation, leading to further prevention of anemia (41). Here, SF3B1 is linked to myelodysplastic syndrome.